Helix BioPharma Corp.

(HBP:PUR)

By |

Profile

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its drug product candidates are L-DOS47, V-DOS47.The company has Tumor defense breakers and Tumor defense attackers product candidates in the pipeline.

Contact Information

Website: www.helixbiopharma.com
Email: helix@helixbiopharma.com
Main Phone: +1 905 841-2300
Address: 9120 Leslie Street
Address 2: Suite 205
State: ON
City / Town: Richmond Hill
Country: CAN
Postal Code: L4B 3J9

Issuer Information

Exchange: TSX
CEO: Heman Chao
Employees: 22
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 2.12 $ 0. (0.00%)
Last Price 2.12 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 2.12
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap 222.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 104,916,579.00 EPS (TTM) -0.09 PE Ratio N/A Exchange TSX
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1